| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.11 | 0.009 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |